SCUVX
Price
$31.13
Change
+$0.20 (+0.65%)
Updated
Jul 31 closing price
Net Assets
171.96M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SCUVX vs VSCIX

SCUVX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SCUVX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCUVX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SCUVX (172M). VSCIX pays higher dividends than SCUVX: VSCIX (1.23) vs SCUVX (0.00). SCUVX was incepted earlier than VSCIX: SCUVX (20 years) vs VSCIX (29 years). SCUVX (1.43) is less costly to investors than VSCIX (0.03). SCUVX is a more actively managed with annual turnover of: 44.00 vs. VSCIX (17.00). SCUVX has a lower initial minimum investment than VSCIX: SCUVX (2000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. SCUVX (12.59). VSCIX return over 5 years is better than : 35.13 vs. SCUVX (-3.44).
SCUVXVSCIXSCUVX / VSCIX
Total Expense Ratio1.270.034,233%
Annual Report Gross Expense Ratio1.430.034,767%
Fund Existence20 years29 years-
Gain YTD17.25014.591118%
Front Load6%N/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets172M189B0%
Annual Yield % from dividends0.001.23-
Returns for 1 year12.5922.5856%
Returns for 3 years14.1143.4432%
Returns for 5 years-3.4435.13-10%
Returns for 10 years31.75156.0720%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C